Purification of human very-long-chain acyl-coenzyme A dehydrogenase and characterization of its deficiency in seven patients.
Toshifumi Aoyama(Shinshu University), T. Hashimoto(Ōtani University), Richard I. Kelley(Kennedy Krieger Institute), Masayoshi Souri(Yamagata University), Takehiko Kamijo(Saitama Cancer Center), Seiji Yamaguchi(Chubu University), Katsuji Uetake(Hokkaido University), William J. Rhead(Children's Hospital of Wisconsin), S. Ushikubo(Ōtani University), Kay Tanaka(Yale University)
Cited by 164
Related Papers
Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies
|Nature Medicine|2014|843
Survival after Treatment with Phenylacetate and Benzoate for Urea-Cycle Disorders
|New England Journal of Medicine|2007|357
X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduria
|The Journal of Pediatrics|1991|275
Targeted disruption of mouse long-chain acyl-CoA dehydrogenase gene reveals crucial roles for fatty acid oxidation
|Proceedings of the National Academy of Sciences|1998|254
‘Classical’ organic acidurias, propionic aciduria, methylmalonic aciduria and isovaleric aciduria: Long‐term outcome and effects of expanded newborn screening using tandem mass spectrometry
|Journal of Inherited Metabolic Disease|2006|247